Gan & Lee Pharmaceuticals is a Chinese pharmaceutical company based in Beijing that focuses on diabetes treatments. It develops and manufactures recombinant human insulin and insulin analogue products, including long-acting and rapid-acting insulins, along with other biopharmaceutical medicines. Its customers are mainly hospitals, clinics and patients managing diabetes in China and in overseas markets where its products are registered. The company also carries out research on further protein and peptide-based therapies.
On this site Gan & Lee Pharmaceuticals Co Ltd appears as a stock on the Shanghai Stock Exchange (China), code 603087, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #47 of 2280 on the Shanghai Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for China yet.
TrendStrong
93/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average5.1%
From 52-week high-11.8%
MomentumStrong
79/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return5.6%
6-month return13.9%
12-month, skipping last month2.7%
Stability (higher is calmer)Strong
74/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)41.0%
Worst drawdown, 1 year (smaller is calmer)-28.5%
LiquidityStrong
89/100
Trades actively.
See the numbers →
Avg daily value traded737.48M CNY
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for China when fundamentals data for this market is added. All China stocks.
52-wk range 51.51 – 79.99Daily closes, split-adjusted
Signals
50-day average71.05
200-day average65.00
Golden/death cross (60d)Golden, 45 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.25
Technical summary
Daily
Neutral
6 bullish · 2 neutral · 8 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
69.45
Bearish
EMA 10
70.13
Bearish
SMA 20
71.67
Bearish
EMA 20
70.55
Bearish
SMA 50
71.05
Bearish
EMA 50
69.88
Bearish
SMA 100
66.37
Bullish
EMA 100
67.87
Bullish
SMA 200
65.00
Bullish
EMA 200
65.58
Bullish
Oscillators (daily)
RSI (14)
45.16
Neutral
MACD (12, 26)
-0.33
Bearish
Momentum (12)
-9.55
Bearish
Stochastic %K (14)
18.69
Bullish
Williams %R (14)
-81.31
Bullish
CCI (20)
-65.83
Neutral
Pivot points (classic, last session)
S3
61.97
S2
64.98
S1
66.65
Pivot
69.66
R1
71.33
R2
74.34
R3
76.01
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 CNY
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.3000
0.4000
0.7000
Ex-dividend dates and amounts from our market-data provider. Shown as declared, before tax.
Prices are end-of-day closes in CNY. Educational only, not financial advice.
